Knight Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	76.45	80.11	58.76	71.68	85.96
Short-Term Investments	18.83	62.23	95.66	85.83	63.54
Cash & Short-Term Investments	95.28	142.33	154.42	157.51	149.5
Cash Growth	-33.05%	-7.83%	-1.96%	5.35%	-60.34%
Accounts Receivable	127.78	105.2	88.72	94.89	55.39
Other Receivables	6.06	4.34	7.43	11.29	5.06
Total Trade Receivables	133.84	109.54	96.15	106.18	60.44
Inventory	135.87	102.7	91.83	92.49	72.4
Other Current Assets	29.85	42.25	22.71	39.45	22.63
Total Current Assets	394.84	396.81	365.12	395.62	304.97
Net Property, Plant & Equipment	21.93	20.02	17.86	22.63	31.39
Other Intangible Assets	379.51	283.61	289.96	338.78	350.3
Goodwill	89.98	86.48	79.84	82.27	75.4
Long-Term Investments	79.48	103.43	120.02	158.02	178.95
Other Long-Term Assets	80.56	73.45	72.69	57.51	50.88
Total Assets	1,046	963.8	945.49	1,055	991.89
Accounts Payable	120.87	78.35	85.37	106.06	65.31
Short-Term Debt	16.73	17.49	17.85	17.67	26.66
Current Portion of Leases	3.4	2.64	1.73	2.58	1.61
Other Current Liabilities	24.26	12.78	9.09	15.01	11.72
Total Current Liabilities	165.26	111.25	114.03	141.32	105.3
Long-Term Debt	51.17	25.9	44.02	52.4	9.27
Long-Term Leases	6.62	3.43	5.5	5.05	3.42
Other Long-Term Liabilities	55.99	28.11	35.08	30.21	31.89
Total Long-Term Liabilities	113.77	57.44	84.59	87.66	44.57
Total Liabilities	279.03	168.69	198.62	228.98	149.87
Common Stock	530.14	534.27	540.05	599.06	628.85
Additional Paid-in Capital	32.45	25.83	26.11	23.78	21.89
Accumulated Other Comprehensive Income	55.74	80.22	29.83	41.27	-0.38
Retained Earnings	148.94	154.79	150.89	161.76	191.65
Shareholders' Equity	767.27	795.11	746.87	825.86	842.02
Total Liabilities & Equity	1,046	963.8	945.49	1,055	991.89
Total Debt	77.91	49.46	69.09	77.7	40.96
Net Cash (Debt)	17.37	92.87	85.33	79.81	108.54
Net Cash Growth	-81.30%	8.84%	6.92%	-26.48%	-66.16%
Net Cash Per Share	0.17	0.92	0.79	0.69	0.87
Book Value	767.27	795.11	746.87	825.86	842.02
Book Value Per Share	7.71	7.84	6.95	7.19	6.76
Tangible Book Value	297.78	425.02	377.07	404.8	416.32
Tangible Book Value Per Share	2.99	4.19	3.51	3.52	3.34

Updated Mar 19, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.